The 6 most recent market catalysts affecting $GPS, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 4, 2026
Corporate Catalyst
Bearish
Impact 65
Gap 13D/ Amended Filing Shows John J. Fisher Distributes 6.8M Shares; Beneficial Ownership Falls To 13%
The filing reveals that John J. Fisher, a prominent insider, has divested a substantial portion of his Gap shares, specifically 6.8 million, leading to a decrease in his beneficial…
Aug 28, 2026
Corporate Catalyst
Neutral
Impact 75
Gap Submits Eligible International Emergency Economic Powers Act Tariff Refund Claims Of ~$512M In Q2, Receives ~$95M In Tariff Refunds
Gap submitted eligible claims for approximately $512 million in IEEPA tariff refunds, stemming from a U.S. Supreme Court decision invalidating certain tariffs. The company has alre…
Aug 28, 2026
Corporate Catalyst
Bullish
Impact 85
Gap shares are trading higher after the company reported better-than-expected Q2 adjusted EPS results and raised their FY26 EPS guidance above estimates. Also, the company narrowed its FY26 sales guidance above estimates.
This headline is a significant positive catalyst for Gap (GPS). The better-than-expected Q2 adjusted EPS and the raised FY26 EPS guidance, coupled with narrowed sales guidance abov…
Aug 27, 2026
Corporate Catalyst
Bullish
Impact 85
Gap shares are trading higher after the company reported better-than-expected Q2 adjusted EPS results and raised their FY26 EPS guidance above estimates. Also, the company narrowed its FY26 sales guidance above estimates.
This headline is a significant positive corporate catalyst for Gap (GPS). The better-than-expected Q2 adjusted EPS and, more importantly, the raised FY26 EPS guidance, signal impro…
Aug 27, 2026
Corporate Catalyst
Bullish
Impact 85
Gap Raises FY2026 GAAP EPS Guidance from $2.83-$2.93 to $3.77-$3.87 vs $2.47 Est
Gap (GPS) has filed an 8-K to announce a substantial upward revision to its fiscal year 2026 GAAP EPS guidance. The new range of $3.77-$3.87 is significantly above both the previou…
Aug 7, 2026
Corporate Catalyst
Bullish
Impact 85
Guardian Pharmacy Services shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance above estimates. Also, Oppenheimer maintained an Outperform rating on the stock and raised its price target from $43 to $49.
This headline indicates a strong positive catalyst for Guardian Pharmacy Services. The combination of exceeding financial expectations, providing an optimistic future outlook (rais…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.